Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Adjunct, Aerodrome, Aldrich, Arie, Aziyo, Barbara, billion, breakfast, broadly, CDMO, Childhood, chronic, combat, composed, confidence, Costa, Culture, density, Deputy, diagnosed, disrupted, disruption, diversified, EC, epidemic, extend, Fidelio, Floor, fraction, geographically, geography, GGT, globe, glycaemic, glycemic, Hammersmith, heightened, home, Horizon, inadequate, induced, instructed, Jay, Julio, lab, Latin, lessee, marker, Mayer, MCAP, metformin, methodology, Miami, Miller, monotherapy, mutual, nationwide, network, night, nineteen, Nyxoah, outbreak, pandemic, parallel, pattern, pilot, pivotal, Postgraduate, postpone, presidential, proclamation, Programme, proton, Psychology, quarantine, redemption, regrant, reissued, repay, Rica, Rosenstock, Royal, SA, Sigma, Skyler, slandered, SME, Southwestern, spending, spread, spreading, staffing, timeline, TLA, topline, TrialNet, waiting, week, Western, worsen, Wuhan
Removed:
absorption, abstract, added, adirector, administered, AG, appointedChief, appointedPresident, began, beta, calendar, California, call, cardiovascular, charged, clamp, collectability, commence, community, confirmed, consecutive, direction, driven, Eisenberg, emptying, focusing, footnote, gastric, HCW, Hilla, hypoparathyroidism, hypothesized, improved, inflammation, ingested, intake, intravenously, largely, lessor, mouth, nonclinical, noted, occurring, Officerand, owed, par, placement, platform, progressed, quantifying, reducing, release, relief, satiety, sensitivity, stimulated, stimulating, stream, supplemented, therapy, toxicology, unchanged, vascular, Wainwright
Filing tables
Filing exhibits
- 10-K Annual report
- 3.1 Composite Copy of Certificate of Incorporation, As Amended As of January 22, 2013, Corrected February 8, 2013, As Amended As of July 25, 2014, Corrected September 5, 2017 and As Further Amended As of August 3, 2020
- 3.2 Composite Copy of Certificate of Incorporation, As Amended As of January 22, 2013, Corrected February 8, 2013, As Amended As of July 25, 2014, Corrected September 5, 2017 and As Further Amended As of August 3, 2020
- 4.4 Description of Securities
- 23.1 Consent of Kesselman & Kesselman, Independent Registered Public Accounting Firm.
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
ORMP similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
In connection with the annual report of Oramed Pharmaceuticals Inc., or the Company, on Form 10-K for the period ended August 31, 2020, as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Avraham Gabay, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, that to my knowledge:
1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: November 24, 2020 | /s/ Avraham Gabay |
Avraham Gabay | |
Chief Financial Officer |